Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_assertion type Assertion NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_head.
- NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_assertion description "[Together, these data show that pharmacological inhibition of PKC? effectively reduces mammary cancer metastasis by targeting intravasation and lung seeding steps in the metastatic process and suggest that PKC?-specific inhibitors, such as ?V5-3, can be used to study the mechanistic roles of PKC? specifically and may provide a safe and effective treatment for the prevention of lung metastasis of breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_provenance.
- NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_assertion evidence source_evidence_literature NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_provenance.
- NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_assertion SIO_000772 20856202 NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_provenance.
- NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_assertion wasDerivedFrom befree-20150227 NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_provenance.
- NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_assertion wasGeneratedBy ECO_0000203 NP642435.RAWLEgsOg9bYaqyN6X_WHC-2CbT1wepJ-mU8FJC3xxktI130_provenance.